Myovant Sciences Ltd
NYSE:MYOV
Myovant Sciences Ltd
Cash from Financing Activities
Myovant Sciences Ltd
Cash from Financing Activities Peer Comparison
Competitive Cash from Financing Activities Analysis
Latest Figures & CAGR of Competitors
Company | Cash from Financing Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Myovant Sciences Ltd
NYSE:MYOV
|
Cash from Financing Activities
$13.5m
|
CAGR 3-Years
-57%
|
CAGR 5-Years
-15%
|
CAGR 10-Years
N/A
|
|
Centessa Pharmaceuticals PLC
NASDAQ:CNTA
|
Cash from Financing Activities
$21.1m
|
CAGR 3-Years
149%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Autolus Therapeutics PLC
NASDAQ:AUTL
|
Cash from Financing Activities
-$883k
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Bicycle Therapeutics PLC
NASDAQ:BCYC
|
Cash from Financing Activities
$250m
|
CAGR 3-Years
58%
|
CAGR 5-Years
58%
|
CAGR 10-Years
N/A
|
|
Immunocore Holdings PLC
NASDAQ:IMCR
|
Cash from Financing Activities
£34.3m
|
CAGR 3-Years
-33%
|
CAGR 5-Years
221%
|
CAGR 10-Years
N/A
|
|
Genus PLC
LSE:GNS
|
Cash from Financing Activities
-£20.5m
|
CAGR 3-Years
5%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Myovant Sciences Ltd's Cash from Financing Activities?
Cash from Financing Activities
13.5m
USD
Based on the financial report for Dec 31, 2022, Myovant Sciences Ltd's Cash from Financing Activities amounts to 13.5m USD.
What is Myovant Sciences Ltd's Cash from Financing Activities growth rate?
Cash from Financing Activities CAGR 5Y
-15%
Over the last year, the Cash from Financing Activities growth was -74%. The average annual Cash from Financing Activities growth rates for Myovant Sciences Ltd have been -57% over the past three years , -15% over the past five years .